• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Processa Pharmaceuticals Inc (NQ: PCSA )

    1.630 -0.010 (-0.61%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 32,346
    Open 1.640
    Bid (Size) 1.610 (187)
    Ask (Size) 1.710 (21)
    Prev. Close 1.640
    Today's Range 1.610 - 1.660
    52wk Range 1.400 - 18.00
    Shares Outstanding 2,858,007
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Seasoned Veteran as Chief Financial Officer
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial
    Via Investor Brand Network
    Exposures Product Safety

    Performance

    YTD
    -76.96%
    -76.96%
    1 Month
    -16.84%
    -16.84%
    3 Month
    +6.54%
    +6.54%
    6 Month
    -34.93%
    -34.93%
    1 Year
    -78.72%
    -78.72%

    More News

    Read More
    PCSA Stock Earnings: Processa Pharma Reported Results for Q1 2024
    Via InvestorPlace
    How Is The Market Feeling About Processa Pharma?
    Via Benzinga
    BioMedNewsBreaks — Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at Upcoming EF Hutton Global Conference
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Dr. Steven Cha to Lead Clinical Development of Oncology Programs
    Via Investor Brand Network
    Exposures Product Safety
    Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
    Via Benzinga
    Exposures Fossil Fuels
    Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    S&P 500 Down Over 1%; Merck Increases 2024 Outlook
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Dow Dips Over 500 Points; US GDP Growth Misses Expectations
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Presents New Data from NGC-Cap Phase 1b Trial at AACR Annual Meeting
    Via Investor Brand Network
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
    Via Investor Brand Network
    Exposures Product Safety
    TinyGemsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at American Association for Cancer Research Annual Meeting
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at 2024 BIO CEO & Investor Conference
    Via Investor Brand Network
    Exposures Product Safety
    Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $7M Public Offering
    Via Investor Brand Network
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.